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A B S T R A C T 
In patients at risk of intraventrcular thrombosis, the benefits of chronic anticoagulation therapy need to 
be balanced with the pro-hemorrhagic effects of therapy. Blood stasis in the cardiac chambers is a 
recognized risk factor for intracardiac thrombosis and potential cardiogenic embolic events. In this work, 
we present a novel flow image-based method to assess the location and extent of intraventricular stasis 
regions inside the left ventricle (LV) by digital processing flow-velocity images obtained either by phase-
contrast magnetic resonance (PCMR) or 2D coIor-Doppler velocimetry (echo-CDV). This approach is 
based on quantifying the distribution of the blood Residence Time (TR) from time-resolved blood velocity 
fields in the LV. We tested the new method in illustrative examples of normal hearts, patients with 
dilated cardiomyopathy and one patient before and after the implantation of a left ventricular assist 
device (LVAD). The method allowed us to assess in-vivo the location and extent of the stasis regions in 
the LV. Original metrics were developed to integrate flow properties into simple scalars suitable for a 
robust and personalized assessment of the risk of thrombosis. From a clinical perspective, this work 
introduces the new paradigm that quantitative flow dynamics can provide the basis to obtain subclinical 
markers of intraventricular thrombosis risk. The early prediction of LV blood stasis may result in decrease 
strokes by appropriate use of anticoagulant therapy for the purpose of primary and secondary preven-
tion. It may also have a significant impact on LVAD device design and operation set-up. 
1. Introduction 
Cardiovascular diseases are the leading cause of mortality 
worldwide and are projected to cause more than 20 million deaths 
per year by 2030. Cardioembolic stroke is one of the most 
devastating consequences of cardiac diseases, both in terms of 
mortality and disability. Amongst all causes of stroke, the cardi-
oembolic etiology is associated with the highest mortality rate and 
reaches 20% in some prospective series (Arboix and Alio, 2010). 
Three major mechanisms promote intracardiac thrombosis and 
embolism in cardiac diseases. First, endocardial injury, due to 
surgery, chronic stretch or ischemic necrosis, activates clot for-
mation by exposing pro-coagulation factors of the basal mem-
brane. Additionally, cardiac diseases are frequently associated with 
chronic inflammation, and increased catecholamine and inflam-
matory cytokine levels, which induce a systemic hypercoagulable 
state. Finally, blood flow stagnation triggers the activation of the 
coagulation system. These three predisposing factors are classi-
cally known as "Virchow's triad" (Lowe, 2003). Diseases such as 
atrial fibrillation, myocardial infarction, dilated and hypertrophic 
cardiomyopathies are well-established conditions that increase 
the risk of cardiac embolisms by a combination of these three 
mechanisms. 
Anticoagulation therapy has proven to be effective for 
decreasing the risk of cardioembolic events. However, the benefits 
of anticoagulation are frequently neutralized by the increased 
hemorrhagic risk associated with this therapy (Massie et al., 2009). 
In fact, most clinical trials assessing the efficacy of primary pre-
vention of anticoagulation therapy in non-AF cardioembolic dis-
eases have been negative or neutral (Bakalli et al., 2013; Homma et 
al., 2012). These trials have been based on clinical risk factors and 
demographic variables, because precision individualized risk 
assessment methods are lacking. We hypothesize that imaging-
based biomarkers are particularly well suited for this purpose. 
Mechanical left-ventricular-assisted-devices (LVADs) are being 
used as temporary and destination therapies in an increasing 
number of patients with end-stage heart failure (HF) (Toeg et al., 
2014). However, intraventricular thrombosis is a well-recognized 
complication of LVADs and may lead to device malfunction and 
embolism. A quantitative and individualized topologic assessment 
of the chamber regions at particular risk for thrombus develop-
ment may help to define the ideal locations for the insertion of the 
LVAD cannulas on a patient-specific basis and, to optimize the 
device operating settings. 
Flow in the heart involves complex fluid transport and mixing 
processes (Bermejo et al., 2015). Intracardiac transport and mixing 
depends on convoluted trajectories of flow inside the chambers 
(Kilner et al., 2000; Wigstrom et al., 1999; Zhang et al., 2012) as 
well as on the dynamical interactions between incoming flow and 
residual flow from preceding cycles (Bolger et al., 2007). In the 
healthy heart, these phenomena result in a small residual volume 
with no associated blood stasis. However, intraventricular flow 
patterns are significantly altered by disease (Bermejo et al., 2014; 
Eriksson et al., 2013; Hong et al., 2008; Rodriguez Munoz et al., 
2013). How these disturbed flow dynamics may lead to increased 
blood stasis is only beginning to be understood (Eriksson et al., 
2013; Hendabadi et al., 2013). 
Currently, there are no tools capable of a high-throughput 
measurement of flow stasis in the clinical setting. There have 
been only a few attempts to define indices of intraventricular 
blood stasis using in vitro and computational models (Quaini et al., 
2011; Wong et al., 2014). However, most of these indices are based 
on Eulerian flow metrics and therefore fail to capture the intricate 
unsteady nature of blood flow transport, as well as the mixing 
between the blood volume entering the LV each heart beat and the 
residual volume from preceding ones (Hendabadi et al., 2013). 
The present study was designed to implement a novel method 
for measuring and mapping blood stasis in the heart. The purpose 
was to obtain individual quantitative metrics of global and regio-
nal stasis from flow-velocity measurements in the LV. The feasi-
bility of the method was first tested in a high-resolution three-
dimensional dataset of LV flow velocity obtained in a large animal 
by phase-contrast magnetic resonance (PCMRI). To generalize the 
applicability of the tool we also adapted the method to work with 
ultrasound data. We analyzed data from healthy and diseased LVs, 
as well as before and after LVAD implantation. We demonstrate 
the unique ability of the tool to identify and track the regions at 
risk of blood stagnation, providing qualitative and topological 
assessments of blood stasis in the LV. 
2. Methods 
2.2. Study population 
The present study is based on the following data: 1) high-
resolution 3D PCMRI data from a pig scanned under highly con-
trolled heart and respiratory rates, and 2) color-Doppler ultra-
sound datasets from 2 patients with non-ischemic dilated cardi-
omyopathy (NIDCM), one healthy volunteer without known heart 
disease and no cardiovascular risk factors, and one patient with 
end-stage HF both before and after LVAD implantation. Ultrasound 
datasets were randomly selected from a large database of two-
dimensional velocity maps recruited at our institutions. The study 
protocol was approved by the local institutional review committee 
and all subjects provided written informed consent for this study. 
Clinical data are summarized in Table 1. 
2.2. 3D PCMRI, image acquisition and processing 
A high-resolution 3D PCMRI of the LV together with its corre-
sponding 3D anatomical images were obtained in a male Large 
White pig under anesthesia, using a 3T magnet (Achieva-Tx, Phi-
lips Medical Systems, Best, the Netherlands), equipped with a 32-
channel cardiac phased-array surface coil. Images were acquired 
during spontaneous ventilation using retrospective electrocardio-
graphic gating. 3D PCMRI images were planned in a standard 4-
and 2-chamber view to cover the entire LV from the level of the 
mitral annulus to the apex. The following imaging parameters 
were used: FOV 240 x 240 mm2, voxel size 0.94 x 0.94 x 2 mm3, 
1 NEX, SENSE 2, with 25 reconstructed heart phases, corre-
sponding to a time resolution of 34 ms, PC flow directions RL-AP-
FH, act. TR/TE (ms) = 6.0/3.7 and VENC of 100cm/s, as similarly 
reported (Garcia-Alvarez et al., 2013). The velocity field inside the 
ventricle was obtained from the phase data after correcting for 
phase-aliasing artifacts through phase unwrapping of closed 
regions with abnormal intensity gradient. Each anatomical image 
was post processed using a semi-automatic volume segmentation 
tool in order to obtain the ventricle boundary surface throughout 
the cardiac cycle. The segmentation method is based on a multi-
resolution level-set active contour optimized for heart segmenta-
tion (Gonzalez et al., 2015). 
2.3. 2D image acquisition, analysis and processing 
Comprehensive 2-dimensional (2D) B-mode and color-Doppler 
echocardiographic examinations were performed using a Vivid 
7 scanner and 2-4 MHz transducers (General Electric Healthcare). 
The LV myocardial wall was segmented, and its longitudinal and 
transversal strains were measured from the apical long-axis 
B-mode sequences to delineate the endocardial boundary (Echo-
Pac v.110.1.2, General Electric Healthcare). We reconstructed the 
2D+t flow field inside the LV using 2D echo color Doppler velo-
cimetry (echo-CDV), as previously described and validated in vitro 
(Garcia et al., 2010) and in vivo (Bermejo et al., 2014). The 2D flow 
velocity fields together with the LV segmentation were used to 
integrate the unit-forced transport equation and to calculate the 
spatio-temporal evolution of blood residence time inside the LV 
(see below). Conventional Doppler-echocardiographic data was 
recorded following current recommendations (Lang et al., 2015). 
2.4. Residence time 
2.4.1. Evolution equation for residence time 
The time spent by a blood particle inside the LV can be eval-
uated by a scalar magnitude known as residence time (TR). Using a 
Lagrangian approach, TR evolution can be described by the 
advection equation with unit forcing, 
djR + V^injR) = 1, (1) 
where v
 inc is the velocity field. Previous works have considered a 
similar equation with a non-zero mass diffusivity term (Esmaily-
Moghadam et al., 2013; Jozsa and Kramer, 2000; Mangual et al., 
2012), but we note that the self-diffusivity of blood is negligible 
compared to its advective fluxes inside the LV (Bermejo et al., 
2015; Tarbell, 2003). The full derivation of Eq. (1) can be found in 
Appendix 1. In the absence of a diffusive term, Eq. (1) can be 
completed with Dirichlet boundary conditions at the inlet, Sin, 
when the blood coming from the left atrium enters the ventricle 
domain V¡y. Eq. (1) was numerically integrated on a Cartesian grid 
using a second-order Finite Volume discretization, in which TR and 
v
 inc were respectively interpolated at each cell's center and faces. 
We used a Total Variation Diminishing (TVD) flux limiting 
scheme (LeVeque, 2002) to avoid the numerical oscillations that 
would appear at the sharp interfaces created by the transport 
process, particularly between fresh blood entering the LV each 
cycle and the residual blood from previous cycles. A second-order 
time integration scheme was adopted keeping the Courant-Frie-
drichs-Lewy (CFL) number below 0.5 throughout the whole inte-
gration and using a variable time step, At, bounded between 5-
0.3 ms for the 2D-echo-CDV and 33-0.5 ms for the 3D PCMRI data. 
The velocity field at each integration step was obtained by linearly 
interpolating in time the previous and the successive velocity 
acquisition data frames. 
Spatio-temporally connected pixels with high residence time 
(e.g. TR > 2 s) were clustered and stored for further analysis using 
in-house algorithms. Clusters smaller than 2% LV volume (area in 
2D) and clusters that did not span the whole cardiac cycle were 
discarded and were not analyzed further. 
Table 1 
Clinical data of the studied cases. 
ID 
HEALTHY 
NIDCM-1 
NIDCM-2 
PRE-LVAD 
POST-LVAD 
PIG 
Age 
51 
47 
64 
63 
63 
1 
Gender 
F 
M 
F 
F 
F 
M 
Regional wall 
motion 
Normal 
Inferior and pos-
terior akinesis 
Global 
hypokinesis 
Inferior and sep-
tal akinesis 
LVAD 
Normal 
H.R. 
(b.p. 
m.) 
64 
80 
76 
68 
100 
76 
EDV 
(mL) 
98 
81 
154 
156 
84 
-
ESV 
(mL) 
31 
62 
117 
111 
63 
-
EF(%) 
68 
24 
24 
29 
25 
-
HR: Heart rate, EDV: End-Diastolic Volume, ESV: End-Systolic Volume, EF: Ejection 
fraction, HEALTHY: healthy volunteer; NIDCM: non-ischemic dilated cardiomyo-
pathy; LVAD: left ventricle assist device. 
2.4.2. PCMRI velocity correction for mass conservation 
Similar to other flow measurement techniques, PCMRI provides 
velocity fields with noise that usually do not satisfy mass con-
servation (i.e. V»v"c # 0). Although noise can be minimized by 
appropriate fine-tuning during data acquisition, appreciable errors 
remain in current state-of-the-art PCMRI measurements (Busch et 
al., 2013). Errors in mass conservation are particularly troublesome 
for the purpose of analyzing blood transport and residence time 
because they introduce a spurious source term equals to -TRV> 
v
 inc in the transport Eq. (1). This spurious term can generate 
undesired variations in TR that are not caused by convective blood 
transport. 
In this work, we apply a solenoidal projection method to 
enforce the condition that the PCMRI velocity field is incompres-
sible (Chorin, 1967). Note that, since the echo-CDV fields are 
derived by enforcing mass conservation (Garcia et al., 2010), they 
automatically satisfy this condition. Briefly, a velocity field derived 
from a potential function cp is added to the original field, 
v
 0:v inc= v 0 + V(p. Imposing that v inc is divergence-free allows 
for calculating cp by solving a Poisson's equation with non-
homogeneous Neumann boundary conditions at the LV walls. 
This problem was solved using a custom Multi-Grid method 
developed in FORTRAN, interpolating the original domain onto a 
Cartesian grid. The moving boundary was defined independently 
of the Cartesian grid by using a sharp interface immersed 
boundary method (Mittal et al., 2008). 
2.4.3. Grid sensitivity analysis 
While time-resolved 3D PCMRI provides invaluable information 
about the multi-dimensional flow transport and stasis patterns in the 
LV, the moderate spatio-temporal resolution (Ax=Ay=0.94 mm, 
Az=2 mm and At=33 ms) of this technique could pose a potential 
limitation. To rule out this possibility, we performed a sensitivity 
analysis of the dependence of the TR maps on the time and space 
resolution in the echo-CDV data, which is better resolved 
(Ax=0.5 mm and At=5ms). We progressively deteriorated the 
resolution of N=3 echo-CDV datasets and computed the average L2 
norm of the error in the TR fields as a function of Ax and At. Table 2 
summarizes the results of this analysis, and suggests that the reso-
lution of the PCRMI data used in this work was sufficient to accu-
rately resolve the spatiotemporal evolution of the residence time. 
2. Results and discussion 
2.1. Residence time in 3D 
The 3D+t spatiotemporal distribution of TR in the LV was cal-
culated from PCMRI data. Fig. 1 displays 3D renderings of TR at 
mitral valve opening and at isovolumic contraction. The velocity 
field shows the strong diastolic jet and associated vortex ring that 
characterizes LV filling flow (Bermejo et al., 2015). In this ventricle 
Table 2 
Sensitivity analysis over 6 beats (6 T): mean + standard deviation, of the L2 norm of the error, defined below, compared to the reference frame in 3 different cases. 
Herri, 
Nx x Ny, dx [mm] 
ü=f!a TR-TR dxdy dt/ft'=^faTR dxdy dt 
dt [ms] 
Number of input frames 
3.9 + 0.4 
200 
7.8 ±0.7 
100 
¡5.7+1.5 
50 
39.2 + 3.8 
20 
78 + 7.5 
10 
256 x 256, 0.35 + 0.02 
128x128, 0.70 ±0.04 
64 x 64, 1.42 ± 0.08 
32 x 32, 2.88 ± 0.16 
16 x 16, 5.96 ± 0.32 
Reference: TR 
0.123 + 0.018 
0.212 + 0.027 
0.295 + 0.028 
0.394 + 0.035 
0.022 + 0.015 
0.124 + 0.018 
0.21 + 0.028 
0.293 + 0.029 
0.395 + 0.036 
0.121 + 0.02 
0.154 + 0.02 
0.218 + 0.03 
0.293 + 0.029 
0.401 + 0.041 
0.15 + 0.039 
0.173 + 0.029 
0.227 + 0.024 
0.296 + 0.028 
0.406 + 0.055 
0.297 + 0.104 
0.28 + 0.092 
0.282 + 0.075 
0.32 + 0.049 
0.396 + 0.035 
the region of highest TR is located close to the apex, and extends 
towards the aortic tract along the anteroseptal wall. This residence 
time pattern agrees well with the pattern observed in normal 
human LVs (see example in Fig. 2A). The three-dimensionality of 
the TR field is evident in Fig. 1, and is caused by the complexity of 
intraventricular blood flow and transport during the cardiac cycle. 
However, the main features of this field are relatively well cap-
tured in the three-chamber view (delineated by the magenta 
contour in Fig. 1), particularly the maximum value of TR and its 
apical location. This result is important because our approach to 
estimate TR using conventional echocardiography is performed 
from velocity fields acquired in the three-chamber view. 
2.2. LV residence time in non-ischemic dilated cardiomyopathy 
Dilated cardiomyopathy is a condition associated with 
increased risk of intraventricular thrombosis. The normal LV flow 
pattern has been reported to recycle the blood volume inside the 
left ventricle every 2-3 beats (Fig. 2A) (Bolger et al., 2007; Eriksson 
et al., 2010; Hendabadi et al., 2013; Watanabe et al., 2008). 
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Fig. 1. 3-D intraventricular velocity field and residence time map in a pig at mitral valve opening (A) and at the end of filling (B). The wireframe contour depicts the LV 
volume segmentation. The magenta and contour lines identify the long-axis plane that contains the mitral valve, apex and aortic valve. The vortical structures in purple are 
visualized by isosurfaces of kci (imaginary part of the complex conjugate eigenvalue of Vv). (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of this article.) 
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Fig. 2. Snapshots of 2-D intraventricular residence time along the cardiac cycle in a healthy heart (A) and in two different examples of patients with non-ischemic dilated 
cardiomyopathy (NIDCM) patients (B, C). 1st row: Residence time mapping at the mitral valve opening in the converged N-1 cycle. 2nd row: Residence time mapping at peak 
E-wave in the last computed cycle. 3rd row: Residence time mapping at the iso-volumetric contraction in the last computed cycle. 4th row: Residence time mapping at mitral 
valve opening in the last cycle. Notice that in both NIDCMs there coexist different regions with high Tr. 
Fig. 3. Snapshots of 2-D K and Ts before mitral valve opening in the last converged cardiac cycle in a healthy heart (A) and in two different examples of patients with NIDCM 
(B, C). 1 st row: Kinetic energy density (K) mapping in the regions with in the regions with TR > 2 s. 2nd row: Distortion time (Ts) in the regions with TR > 2 s. The NIDCM-2 
case is at risk of apical blood stasis given the combination of low K and large Ts. 
However, blood transport is significantly altered in patients with 
NIDCM by the large swirling flow patterns typical of this condition 
(Fig. 2B and C) (Bermejo et al., 2014; Hendabadi et al., 2013). In 
these patients, blood is trapped inside long-lasting vortices and 
undergoes rotation throughout most of the cardiac cycle (see 
Supplementary movie 1). Thus, proper assessment of intraven-
tricular stasis should consider factors such as the distortion of fluid 
particles and their kinetic energy density in addition to TR. The 
kinetic energy density of a fluid particle, defined as 
K = (u2 +v2)/2, can be used together with TR as an intuitive indi-
cator of stasis. However, kinetic energy is not a Galilean invariant 
and it could be possible for a fluid parcel to have high values of K 
while moving with little distortion, similar to a rigid solid. The 
distortion of a fluid particle can be quantified by the second 
invariant of the symmetric strain tensor S,j= (dXj.u¡+dXju¡)/2. For 
an incompressible flow, the first invariant of S,j is zero and the 
second invariant is defined as Qs = trace ÍS? J/2. Note that Qs has 
dimensions of squared inverse of time, so it can be used to define a 
second stasis timescale Ts = Qs 1/2 in addition to TR. 
Supplementary material related to this article can be found 
online at http://dx.doi.org/10.1016/jjbiomech.2015.ll.049. 
Fig. 3 shows the spatial distributions of K and Ts in the regions 
with TR > 2 s for the same subjects of Fig. 2, at the end of diastole. 
As expected, the normal LV (Fig. 3A) does not show any significant 
region with TR > 2 s. There is a small cluster located near the 
endocardium but it has relatively high K and low Ts. Interestingly, 
both dilated LVs (Fig. 3B and C) show large regions with TR > 2 s 
located at the center of the chamber but these regions are asso-
ciated with high values of K and low values of Ts. This indicates 
that blood is continuously being stirred by the LV flow patterns in 
this centrally located region despite having high TR. By contrast, 
the second diseased LV (Fig. 3C) shows a separate, apically located 
region with TR > 2 s that also has low K and high Ts, and is 
therefore stagnant. These results illustrate how the combined 
analysis of the spatio-temporal Lagrangian patterns of residence 
time and Eulerian measures of fluid motion and distortion can 
provide clinically accessible information about intraventricular 
blood stasis from conventional color-Doppler datasets. 
2.3. Changes in blood stasis after LVAD implantation 
Implantable cardiac assist devices, particularly LVADs, alter the 
physiological blood flow patterns in the heart, leading to increased 
risk of thrombosis (Bluestein, 2004; Wong et al., 2014). Among the 
three elements of Virchov's triad, abnormal flow patterns present 
the most complex challenge to improve device design and post-
implantation patient management (Kormos, 2015). However, 
blood stasis has not been previously measured in the patients 
implanted with LVADs. 
Fig. 4 shows residence time maps along a cardiac cycle in a 
patient with NIDCM, mitral regurgitation and end-stage HF before 
and 1 month after LVAD implantation. The pre-LVAD condition 
(Fig. 4A) shows a large region with TR > 2 s located at the center of 
the chamber, which is caused by the large swirling region that is 
sustained during most of the cardiac cycle in this dilated heart. 
This large swirling pattern is indicated by the circular instanta-
neous streamlines in Fig. 4A. Consistent with the results presented 
in Fig. 3, this region is associated with relatively high values of 
kinetic energy density and low values of Ts, implying that this 
region is not stagnant. However, this flow and stasis pattern are 
significantly altered after LVAD implantation, as the flow is chan-
neled from the mitral annulus to the LVAD inflow cannula located 
at the LV apex, instead of transiting towards the outflow tract 
(magenta line in Fig. 4B). As a result, a region with high residence 
time, moderate low kinetic energy and moderate low fluid dis-
tortion (moderately high Ts) appears near the LV outflow tract. 
These factors combined are the hallmark of blood stasis, suggest-
ing a hemodynamic explanation for clinical reports of mural 
thrombosis in the LV outflow tract of LVAD-implanted patients 
(May-Newman et al., 2013). These in vivo results are in agreement 
with previous in vitro experiments performed using a cardiac 
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Fig. 4. Snapshots of 2-D intraventricular residence time along the cardiac cycle in a patient before (A) and after (B) LVAD implantation. The apically located inflow LVAD 
cannula is represented in magenta. 1st row A: Residence time mapping at the mitral valve opening in the converged N-1 cycle. 2nd row: Residence time mapping at E-wave 
peak in the last computed cycle. 3rd row: Residence time mapping at the onset of isovolumic contraction in the last computed cycle. 4th row: Residence time mapping at 
mitral valve opening in the last cycle. 
simulator (Wong et al., 2014), although it should be noted that the 
drastic LV volume unloading caused by LVAD implantation was not 
modeled in the in vitro study. 
2.4. Simplified residence time indices 
An additional challenge in introducing clinically relevant indi-
ces of LV blood stasis is to incorporate metrics that integrate the 
spatio-temporal nature of the TR distributions, together with 
additional parameters such as K or Ts, into simple metrics that can 
be used to compare values between patients. Therefore, we iden-
tified Lagrangian clusters of residual volume formed by spatio-
temporally connected pixels with TR > 2 s (Fig. 5A and Supple-
mentary movie 2), and plotted the following indices as a function 
of time for each Lagrangian cluster: 1) Relative LV volume (area in 
2D) occupied by each cluster (VTR, Fig. 5B), 2) spatially-averaged 
value of TR in each cluster (TRM,2, Fig- 5C), 3) spatially-averaged 
value of K in each cluster (KM,2. Fig. 5D), and 4) spatially-averaged 
value of Ts in each cluster {JSMZ, Fig. 5E). 
The temporal profiles of V^ varied periodically, implying that the 
numerical integration of Eq. (1) achieved numerical convergence. 
Consistent with the instantaneous maps in Fig. 2, the diseased hearts 
showed higher values of VJR than the healthy volunteer throughout 
the cardiac cycle. Remarkably, in the NIDCM cases, the profiles of TRM? 
increased from beat to beat, indicating that there is a persistent resi-
dual volume of blood that does not mix with incoming blood in these 
ventricles. Conversely, TRM? varied periodically for the healthy case, 
suggesting that blood is not indefinitely trapped in healthy ventricles. 
Separate analysis of each TR > 2 s Lagrangian cluster for diseased LVs 
showed that the apically located residual volume in NIDCM case 2 had 
significantly higher values of TSM,2 and significantly lower values of 
KM2 than all other residual volumes in NIDCM cases 1 and 2. These 
data suggest that it is possible to derive simplified indices of stasis 
from the Doppler-derived spatio-temporal maps of TR, Ts and K. Fur-
thermore, our results indicate that individual analyses of intraven-
tricular residual volumes help to unmask blood stasis in patients with 
more than one residual volume region. 
To further simplify the potential clinical application of these stasis 
indices, we considered temporally averaging the time-varying indices 
defined above for each Lagrangian cluster of residual volume. The 
time-averaged indices are denoted with an overline (e.g. VTO) and are 
summarized in Table 3 for the subjects analyzed in this pilot study. To 
facilitate the identification of each cluster, its normalized average 
apical location, XA, is included in the table (0 indicates basal and 
1 indicates apical). Despite the small number of cases, we found 
marked differences in time-averaged stasis indices in patients with 
NIDCM and healthy volunteers, as well as in the patient with HF 
before and after LVAD implantation. The values of VTR in the diseased 
LVs ranged between 20% and 50%, much higher than the healthy case 
which had less than 2.5%. The secular variation of TRM? in the diseased 
cases rendered TRM>2 meaningless in those cases. Conversely, the 
values of KM 2 and TSM,2 were not relevant in the healthy case and for 
the secondary residual volumes of cases NIDCM 1, NIDCM2 and the 
pre-LVAD case, which had insignificant size. Consistent with the 
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Fig. 5. Example of region tracking (A) and time evolution of VTR (B), TM,2 (C), KM,2 (D). TSM,2 (E) along the last converged cycle in all the 2-D studied cases: healthy heart (1st 
col), NIDCM-1 (2nd col), NIDCM-2 (3rd col), pre-LVAD (4th col) and post-LVAD (5th col). Line colors correspond to each of the tracked regions (row A) and their average 
(black) (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.). 
Table 3 
Time-averaged stasis indices for the cases under study. 
Case # Residual volumes Cluster vS" (nor.) TW7 (s) W ( s ) V ^ m J / m 3 ) X7 (nor.) \ W (nor.) T k ^ ( s ) T ^ (s) K ^ (mj/m3) 
(TE > 2 s clusters) 
HEALTHY 1 
NIDCM-1 2 
NIDCM-2 2 
PRE-LVAD 2 
POST-LVAD 1 
1 
1 
2 
1 
2 
1 
2 
1 
0.023 
0.26 
0.025 
0.14 
0.068 
0.47 
0.023 
0.17 
2.33 
Secular 
Secular 
Secular 
Secular 
Secular 
Secular 
Secular 
0.64 
0.25 
0.43 
0.48 
4.3 
0.28 
0.66 
0.45 
2.0 
13.4 
2.1 
4.8 
0.19 
10.0 
2.2 
4.0 
0.92 
0.43 
0.85 
0.28 
0.86 
0.51 
0.40 
0.32 
0.14 
0.10 
0.25 
Secular 0.34 7.74 
Secular 2.36 2.49 
secular 0.47 4.03 
HEALTHY: healthy volunteer; NIDCM: non-ischemic dilated cardiomyopathy; LVAD: left ventricle assist device. VTR: Normalized fraction of chamber volume (Area in 2D) 
occupied by blood with TR > 2 s, averaged over the cardiac cycle. TRM2: Mean residence time in the region with TR>2 s, averaged over the cardiac cycle. TSM,2: Mean 
distortion time scale in the region with TR > 2 s, averaged over the cardiac cycle.KM 2 : Mean kinetic energy density in the region with TR > 2 s, averaged over the cardiac cycle. 
XA: Normalized average cluster apical location. Subindex 0 denotes the average of all the regions with TR > 2 s. 
results presented in the previous sections, the apical residual volume 
of NIDCM case 2 had an appreciable size (V^ s» 7%), its value of KM 2 
was considerably low and its value of TSM,2 was considerably high. 
Likewise, in the LVAD patient, VTR, KM 2, and TSM,2 reflect the increase 
of blood stasis risk near the outflow tract after LVAD implantation. 
These results suggest that the time-averaged stasis indices were able 
to capture the subtle differences in the spatio-temporal stasis patterns 
found in those two ventricles. Further analysis with larger patient 
populations and validation with patient outcomes (e.g. incidence of LV 
thrombus formation) are required to confirm these trends. 
3. Conclusions and study limitations 
In this paper, implement an in vivo method to generate multi-
dimensional spatio-temporal maps of LV blood stasis. We also 
derive simplified patient-specific stasis metrics that integrate 
these maps and can be used to guide personalized clinical 
decision-making. This new method is based on the quantification 
of the residence time spent by blood particles inside the LV since 
entering the chamber, which is obtained by integrating a transport 
equation with unit forcing. A residence time threshold can be used 
to automatically segment and label residual blood volumes that do 
not mix with the fresh blood entering the LV each cardiac cycle, 
and which are potentially stagnant. By analyzing the kinetic 
energy and the rate of distortion of each one of these residual 
volumes we were able to discern if blood is stagnant inside of 
them. This semi-Lagrangian categorization has been shown to 
anticipate thrombogenic regions in a pilot study in patients with 
acute myocardial infarction (Devesa et al., 2015). 
To illustrate the residence time mapping methodology, we 
assessed intraventricular blood stasis in several representative 
examples. The healthy LV presented residual volumes of small size 
in comparison to NIDCM patients. Conversely, we often observed 
large residual volumes inside the persistent swirling flow patterns 
that develop in dilated LVs (Bermejo et al., 2014). These results are 
concordant with previous studies based on echo-CDV and PCMRI 
(Bolger et al., 2007; Eriksson et al., 2010, 2011; Hendabadi et al., 
2013). 
Further analysis of the fluid's kinetic energy and rate of dis-
tortion suggests that, although the blood inside these residual 
volumes barely mixes with fresh blood entering the LV each car-
diac cycle, it is continuously stirred by the surrounding fluid. 
Therefore, we conclude that the large swirling flow pattern that 
develops in dilated LVs does not necessarily induce blood stasis. In 
addition to this frequent pattern, some diseased LVs had other 
regions of high residence time that were also associated with low 
kinetic energy and low rates of distortion, and which were effec-
tively stagnant. Thus, the new method proposed in this paper 
allows clinicians to assess the degree of intraventricular blood 
stasis on an individualized basis. Future trials are obviously 
necessary to address whether this method is suitable to predict 
the risk of intraventricular thrombosis and, eventually, cardioem-
bolic events. The possibility of Lagrangianly tracking and analyzing 
each residual volume inside the LV at low computational costs is 
instrumental for this purpose. 
By combining echo-CDV and residence time mapping, we 
obtained the first quantification of intraventricular blood stasis in 
patients with LVADs. Our results suggest that intraventricular 
blood stasis in the LVAD-assisted heart can be higher than prior to 
implanting the device, particularly near the left ventricular out-
flow tract, a region reported to be thrombogenic during con-
tinuous LVAD support (May-Newman et al., 2013). Mapping 
methods as the one proposed herein show an excellent potential 
to correlate stagnant regions with local and global wall motion 
abnormalities. This type of analysis may be useful in optimally 
choosing the insertion sites for the LVAD cannulas on a per-
patient basis. 
The proposed methodological framework relies on clinical 
access to time-resolved LV velocity fields but is independent of the 
imaging modality employed to measure intraventricular velocity. 
In this work, we exploited this flexibility to obtain TR maps from 
both 3D+t PCMRI and 2D+t echo-CDV velocity fields. This 
allowed us to use each modality to evaluate the limitations of the 
other, namely the spatiotemporal resolution in PCMRI and the 
planar flow simplification in echo-CDV. The analysis of residence 
time maps derived from 3D+t PCMRI showed that both the key 
spatial features and numerical values of TR are well represented in 
the long-axis three-chamber plane imaged by 2D echo-CDV. We 
performed a sensitivity analysis on echo-CVD data with progres-
sively coarsened spatial and temporal resolutions, concluding that 
the resolution of the PCRMI velocity fields used in this work was 
adequate to accurately quantify intraventricular blood stasis. 
However, we noticed that this method may be sensitive to low-
scale velocities. Future clinical studies are needed to optimize the 
adjustments of the VENC scale (PCMRI) and the Nyquist limit 
(Doppler) for the purpose of quantifying stasis. 
Currently, LV blood stasis is not assessed in the clinical setting. 
Echo-CDV has important practical advantages, as it is fast, clini-
cally feasible, does not require infusion of contrast agents, and it 
can be safely performed in patients implanted with LVADs. A 
limitation of this approach is that it neglects the presence of 
intraventricular anatomical elements such as papillary muscles 
and endocardial trabeculae, which can locally increase mixing 
(Bermejo et al., 2015). This may be particularly important at the 
endocardial surface, where our approach predicts high residence 
time values. This limitation could be addressed by including a 
mass-diffusivity term in Eq. (1) with a spatially varying coefficient 
that would need to be determined from high-resolution anato-
mical imaging. Additionally, there is no doubt that the planar flow 
simplification may lead to inaccuracies in the estimation of LV 
blood transport. However, the impact of these and other technical 
issues needs to be balanced against the potential clinical benefit 
offered by the new method. In this context, a pilot study suggests 
that echo-CDV-derived indices of blood stasis may be able to 
predict LV thrombus formation in patients with acute myocardial 
infarction (Devesa et al., 2015), a condition in which an indivi-
dualized assessment of the risk of thrombosis is particularly 
necessary. If these promising results are confirmed in further 
trials, it is possible that the clinical information provided by the 
quantitation of stasis using conventional ultrasound outweighs by 
far the technical limitations of the method. 
In summary, we have implemented a method to quantify and 
map intraventricular stasis from flow-velocity measurements 
which is suitable for bedside clinical application. Using this 
method, important physiological consequences of a number of 
cardiovascular procedures can now be addressed. Interventions 
such as valve replacement, resynchronization therapy, correction 
or palliation of congenital cardiac defects, and surgical ventricular 
restoration are all known to heavily disturb physiological flow 
dynamics. Why and to what extent these procedures may impact 
stasis can be clarified. Spatial, temporal and velocity resolution of 
current imaging modalities are rapidly increasing, potentially 
allowing this type of analyses in other cardiac chambers. The final 
objective of obtaining a reliable individual assessment of the risk 
of cardiac thrombosis, useful for tailoring anticoagulant therapy 
and programming cardiac interventions such as LVADs on a 
patient specific basis, seems therefore achievable in the near 
future. 
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Appendix 1. Derivation of the residence time equation 
In this section, we derive the continuum equation for the 
residence time of a fluid parcel based on the stochastic analysis of 
the residence time of its constituent particles. The stochastic 
derivation is done in ID without loss of generality. 
We consider a fluid particle with position, x, which varies as the 
particle moves with local flow velocity.v, and due to Brownian 
fluctuations. The Langevin equations for the particle's position and 
residence time, 7", are 
dx 
di = 
dT 
dt~~ 
:V + 2Vfc£(t), 
1, 
(2) 
(3) 
where £(t) is a random forcing with a Dirac delta correlation 
function, and k is the diffusivity of the fluid particle within the rest 
of the fluid (Gardiner, 2004). From these equations, it is straight-
forward to derive the Fokker-Planck equation for the probability 
density function, p(x,T,t), 
dp 
dt' 
d(vp) 
dx 
dp
 k^P 
dT+ dx2- (4) 
Notice that the relevant coefficient in Eq. (4) is diffusivity and 
not the viscosity, as at a microstructural level mass diffusion 
between two instants of time requires change of position while 
momentum diffusion requires particle collision, which can occur 
without change of position. To obtain an equation for the con-
tinuum residence time, one can multiply by T Eq. (4), yielding to 
am. 
dt 
d(Tvp) dp , ,d2(Tp) 
dx -
ri+fc- dx1 (5) 
This equation can be integrated in T between + infinity to 
obtain a governing equation for the ensemble average of T, 
TR(x,t)-- Tp(x, T, t)dT, (6) 
which is the residence time of the fluid parcel at each position and 
instant of time. 
The only non-trivial term when integrating Eq. (5) is 
AT, 
, dl 
which can be handled by parts resulting in 
T%iT = Tprao- r pdT=-\. 
i " * ./ — on 
(7) 
(8) 
It is straightforward to see that the first term in the right-
hand-side of Eq. (8) needs to be zero if p is integrable, and that 
the integral of p must be equal to 1 since p is a probability 
density function. Thus, combining Eqs. (5), (6) and (8), one 
arrives at: 
d(TR) 
dt 
d(vTR) 
dx (-!) + /<' d
2(TR) 
dx2 (9) 
The mass diffusivity of blood is customarily considered much 
smaller than its kinematic viscosity, and it is not expected to play 
an important role in influencing particle trajectories, platelet-
surface contact frequency and dissociative binding phenomena 
under flow at physiological shear rates (Fournier, 2012; Leonard 
et al., 1972; Mody and King, 2007; Peattie, 2013). Therefore, we set 
fe=0, which is analogous to previous studies of LV blood transport 
based on the deterministic integration of fluid particle trajectories 
(Hendabadi et al., 2013; Wigstrom et al., 1999). Under these 
premises, Eq. (9) becomes. 
1, 
which is the ID analogous of Eq. (1). 
d(TR) d(vTR) 
dt dx (10) 
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